Your browser is no longer supported. Please, upgrade your browser.
APEN Apollo Endosurgery, Inc. weekly Stock Chart
Apollo Endosurgery, Inc.
Index- P/E- EPS (ttm)-1.63 Insider Own4.30% Shs Outstand21.12M Perf Week-16.67%
Market Cap29.68M Forward P/E- EPS next Y-1.04 Insider Trans0.00% Shs Float13.88M Perf Month-25.92%
Income-34.90M PEG- EPS next Q-0.34 Inst Own61.10% Short Float2.69% Perf Quarter-41.18%
Sales48.20M P/S0.62 EPS this Y45.00% Inst Trans-9.38% Short Ratio14.94 Perf Half Y-51.89%
Book/sh-0.26 P/B- EPS next Y24.80% ROA-46.50% Target Price- Perf Year-55.84%
Cash/sh1.09 P/C1.28 EPS next 5Y- ROE-565.90% 52W Range1.24 - 3.79 Perf YTD-50.88%
Dividend- P/FCF- EPS past 5Y56.00% ROI-43.20% 52W High-63.06% Beta1.05
Dividend %- Quick Ratio0.60 Sales past 5Y58.40% Gross Margin49.90% 52W Low12.90% ATR0.10
Employees217 Current Ratio0.80 Sales Q/Q-18.90% Oper. Margin-57.20% RSI (14)26.39 Volatility5.26% 5.88%
OptionableNo Debt/Eq- EPS Q/Q-279.50% Profit Margin-72.30% Rel Volume0.25 Prev Close1.50
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume25.03K Price1.40
Recom2.50 SMA20-16.26% SMA50-24.76% SMA200-44.02% Volume6,261 Change-6.67%
Apr-28-20Downgrade Piper Sandler Overweight → Neutral $4.50 → $2
Jan-02-19Upgrade Northland Capital Under Perform → Market Perform
Nov-09-18Downgrade Northland Capital Market Perform → Under Perform
Aug-09-18Downgrade Northland Capital Outperform → Market Perform
Jan-04-18Resumed ROTH Capital Buy $9.50
Sep-26-17Initiated Northland Capital Outperform $12
Aug-02-17Initiated ROTH Capital Buy $10
Jul-13-20 01:36PM  
Jul-07-20 07:30AM  
Jun-10-20 04:01PM  
May-04-20 04:01PM  
Apr-30-20 04:15PM  
Apr-14-20 09:13AM  
Apr-13-20 09:00AM  
Mar-31-20 08:27AM  
Mar-28-20 08:57AM  
Mar-26-20 04:00PM  
Mar-24-20 04:30PM  
Feb-13-20 05:52AM  
Dec-30-19 08:41AM  
Dec-22-19 01:52PM  
Dec-12-19 02:30PM  
Dec-02-19 08:00AM  
Nov-25-19 08:00AM  
Nov-12-19 05:42AM  
Nov-04-19 08:00AM  
Oct-30-19 04:05PM  
Oct-25-19 04:00PM  
Oct-15-19 08:00AM  
Sep-18-19 09:00AM  
Sep-03-19 08:55AM  
Aug-12-19 04:03PM  
Aug-08-19 08:00AM  
Jul-23-19 04:03PM  
Jul-19-19 04:00PM  
Jul-17-19 01:44PM  
Jun-24-19 08:00AM  
Jun-14-19 04:02PM  
Jun-13-19 04:02PM  
May-24-19 02:39PM  
May-23-19 06:38PM  
May-15-19 04:00PM  
May-02-19 04:00PM  
Apr-30-19 04:00PM  
Apr-25-19 10:33AM  
Apr-03-19 03:17PM  
Mar-26-19 04:00PM  
Mar-18-19 08:00AM  
Mar-14-19 08:00AM  
Feb-20-19 09:26AM  
Feb-19-19 08:00AM  
Jan-21-19 07:37AM  
Dec-21-18 11:26AM  
Dec-18-18 08:00AM  
Dec-11-18 07:30AM  
Nov-27-18 04:00PM  
Nov-12-18 06:46PM  
Nov-08-18 04:00PM  
Nov-06-18 04:00PM  
Oct-16-18 09:00AM  
Oct-09-18 08:00AM  
Oct-01-18 08:00AM  
Sep-24-18 08:00AM  
Sep-18-18 11:05AM  
Aug-16-18 07:40AM  
Aug-08-18 04:01PM  
Aug-06-18 04:01PM  
Jun-28-18 04:01PM  
Jun-22-18 04:01PM  
Jun-20-18 08:36AM  
Jun-19-18 04:00PM  
Jun-05-18 09:00AM  
Jun-04-18 04:01PM  
May-31-18 05:59PM  
May-24-18 05:44PM  
May-23-18 07:50AM  
May-14-18 05:00AM  
May-08-18 04:01PM  
May-03-18 04:01PM  
Apr-26-18 04:01PM  
Apr-23-18 04:01PM  
Mar-30-18 07:50AM  
Mar-12-18 06:10PM  
Mar-07-18 07:30AM  
Mar-05-18 04:05PM  
Mar-01-18 04:01PM  
Feb-26-18 05:27PM  
Feb-22-18 04:05PM  
Jan-31-18 07:35AM  
Dec-01-17 09:02AM  
Nov-28-17 10:57AM  
Nov-27-17 04:01PM  
Nov-17-17 04:01PM  
Nov-16-17 04:59PM  
Nov-01-17 09:36AM  
Oct-30-17 08:00AM  
Oct-26-17 04:01PM  
Oct-24-17 06:12PM  
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.